The deal paves the way for Form Energy to raise a new funding round before potentially going public next year.
Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into executing malicious JavaScript in their browser, allowing attackers to ...
In clinical communication, it is believed that accurately understanding and appropriately responding to patients’ emotions contributes to treatment effectiveness and patient satisfaction. Recently, ...
Abstract: Accurate estimation of contact forces acting on robotic manipulators is essential for safe and high-performance physical interaction. However, classical disturbance Kalman filter approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results